Craig S. Kussman
Plus aucun poste en cours
Profil
Craig S.
Kussman served as Co-CEO & Chief Financial Officer at Breach Security, Inc., Chief Financial & Administrative Officer at Discovery Partners International, Inc. and SYNAVANT, Inc., Chief Financial Officer & Senior Vice President at Ascenta Therapeutics, Inc., Chief Financial Officer at XIFIN, Inc. and AEON Biopharma Sub, Inc., and Chief Financial & Accounting Officer at Organovo Holdings, Inc. He also worked as a Principal at IQVIA, Inc. and The Dun & Bradstreet Corp.
Kussman holds an undergraduate degree from Pomona College and an MBA from The Wharton School of the University of Pennsylvania.
Anciens postes connus de Craig S. Kussman
| Sociétés | Poste | Fin |
|---|---|---|
| ORGANOVO HOLDINGS, INC. | Director of Finance/CFO | 02/09/2020 |
AEON Biopharma Sub, Inc.
 AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Director of Finance/CFO | 01/08/2016 |
XIFIN, Inc.
 XIFIN, Inc. Packaged SoftwareTechnology Services XIFIN, Inc. engages as a healthcare information technology company. Its products and services include revenue cycle management, laboratory information systems, precision medicine informatics, and digital pathology consultation. The company was founded by L?le White, Donald Lavigne, Michael Coats, and Jeffrey Yates in 1997 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/10/2014 |
| DUN & BRADSTREET CORP | Corporate Officer/Principal | - |
Discovery Partners International, Inc.
 Discovery Partners International, Inc. Miscellaneous Commercial ServicesCommercial Services Discovery Partners International, Inc. (DPI) used to research laboratory looking to discovery pharmaceutical products. It was a small molecule and natural product based drug discovery company that offered collaborations and services complementing the internal capabilities of pharmaceutical and biopharmaceutical. Discovery Partners has actively contributed to dozens of drug discovery collaborations. The company had operations in United States and Europe. The company was founded in 1995 was headquartered in San Diego, CA | Director of Finance/CFO | - |
Formation de Craig S. Kussman
| Pomona College | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORGANOVO HOLDINGS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
IQVIA, Inc.
 IQVIA, Inc. Data Processing ServicesTechnology Services IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT. | Technology Services |
Discovery Partners International, Inc.
Discovery Partners International, Inc. Miscellaneous Commercial ServicesCommercial Services Discovery Partners International, Inc. (DPI) used to research laboratory looking to discovery pharmaceutical products. It was a small molecule and natural product based drug discovery company that offered collaborations and services complementing the internal capabilities of pharmaceutical and biopharmaceutical. Discovery Partners has actively contributed to dozens of drug discovery collaborations. The company had operations in United States and Europe. The company was founded in 1995 was headquartered in San Diego, CA | Commercial Services |
SYNAVANT, Inc.
 SYNAVANT, Inc. Advertising/Marketing ServicesCommercial Services SYNAVANT, Inc. provides Internet marketing solutions to the health care sector. It also offers strategic consulting services that support sales and marketing decision-making and program implementation. The company was founded on August 31, 2000 and is headquartered in Atlanta, GA. | Commercial Services |
The Dun & Bradstreet Corp.
 The Dun & Bradstreet Corp. Data Processing ServicesTechnology Services The Dun & Bradstreet Corp. engages in the provision integrating data and insights services. It offers product to finance, sales and marketing, master data, supplier management, and compliance. The company was founded on July 20, 1841 and is headquartered in Short Hills, NJ. | Technology Services |
Breach Security, Inc.
 Breach Security, Inc. Packaged SoftwareTechnology Services Breach Security, Inc. is the leading provider of real-time, continuous web application integrity and security that protects sensitive web-based information. Breach Security’s products protect web applications from hacking attacks and data leakage, and ensure applications operate as intended. Breach Security’s WebDefend web application security appliance uses bi-directional traffic analysis, automated behavioral profiling and multiple collaborative detection engines to maintain the flow of business-critical traffic while delivering complete protection for payment card data, Social Security numbers and other sensitive information. Based on the world’s most deployed web application firewall, the ModSecurity Pro M1100 web application security appliance offers essential web application security at an affordable price. The M1100 includes the proven, open-source ModSecurity web application firewall software and pre-packaged security rule sets that protect specific environments and prevent data leakage. Breach Security continues to maintain the open-source ModSecurity community and release updates for the software. | Technology Services |
| Cognizant Corp | Commercial Services |
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Health Technology |
XIFIN, Inc.
XIFIN, Inc. Packaged SoftwareTechnology Services XIFIN, Inc. engages as a healthcare information technology company. Its products and services include revenue cycle management, laboratory information systems, precision medicine informatics, and digital pathology consultation. The company was founded by L?le White, Donald Lavigne, Michael Coats, and Jeffrey Yates in 1997 and is headquartered in San Diego, CA. | Technology Services |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | Health Technology |
